Can Ginkgo biloba (100 capsules, 120mg) improve memory and cognitive functions, particularly in cases of dementia?

Ginkgo biloba , a thousand-year-old tree and the sole survivor of its botanical family, fascinates as much for its longevity as for its purported benefits, particularly for brain function. Used for centuries in traditional Chinese medicine, it is now one of the most popular dietary supplements in the world, often marketed to improve memory , concentration, and overall cognitive function . The Ginkgo biloba DETOXIFICATION product - Box of 100 capsules (120mg) - is part of this trend.

However, a particularly sensitive and crucial question arises: can Ginkgo biloba truly help people suffering from cognitive decline, and more specifically those with dementia (such as Alzheimer's disease or vascular dementia)? Given the devastating impact of these diseases, the hope offered by natural solutions is immense, but it is imperative to rigorously and objectively evaluate the scientific evidence.

This article aims to explore in depth the current state of scientific knowledge regarding the effects of Ginkgo biloba on memory and cognitive function, paying particular attention to its potential role in the context of dementia. We will analyze the proposed mechanisms of action, review major clinical studies, discuss safety and interaction issues, and highlight the critical importance of medical advice before considering the use of this supplement, especially for conditions as serious as dementia.

Ginkgo Biloba: A "Living Fossil" at the Heart of Research

Brief History and Traditional Uses

Ginkgo biloba is often called a "living fossil" because it is the only living representative of a very ancient plant family, the Ginkgophyta, whose traces date back more than 270 million years. Native to China, it is revered for its resilience (some specimens survived the atomic bomb dropped on Hiroshima) and exceptional longevity. In Traditional Chinese Medicine (TCM), Ginkgo leaves and seeds were used to treat various ailments, including circulatory and respiratory problems (asthma, bronchitis), and, even then, certain issues related to age-related cognitive decline.

Active Compounds: Flavonoids and Terpenoids

Modern scientific interest in Ginkgo biloba focuses on standardized extracts of its leaves. These extracts contain two main groups of active compounds considered responsible for its biological effects:

• Flavone glycosides (or flavonoids): Primarily quercetin, kaempferol, and isorhamnetin. These compounds are powerful antioxidants . They help neutralize free radicals, unstable molecules that damage cells, including neurons, and contribute to the aging process and many chronic diseases.
• Terpene lactones (or terpenoids): This group is specific to Ginkgo and includes ginkgolides (A, B, C, J) and bilobalide . Ginkgolides are known to be antagonists of Platelet Activating Factor (PAF), a substance involved in platelet aggregation, inflammation, and blood vessel constriction. By inhibiting PAF, ginkgolides could improve blood flow, including to the brain. Bilobalide appears to have neuroprotective effects, helping to protect neurons from damage (e.g., in cases of oxygen deprivation or glutamate excess).

The synergy between these different compounds is probably essential to the observed effects of Ginkgo.

The Importance of Standardization (EGb 761)

The majority of rigorous clinical studies on Ginkgo biloba have been conducted using a specific standardized extract known as EGb 761. This extract is standardized to contain approximately 24% flavone glycosides and 6% terpene lactones (including 2.8–3.4% ginkgolides A, B, and C, and 2.6–3.2% bilobalide). This standardization ensures a consistent concentration of the active ingredients and allows for comparison of results between studies.

It is important to note that not all Ginkgo biloba products on the market necessarily meet the EGb 761 standard. The quality and concentration of active ingredients can vary considerably from one product to another. For the Ginkgo biloba DETOXIFICATION product, it is advisable to check whether the label or description specifies whether it is a standardized extract and according to which standards, in order to better assess its potential in relation to existing scientific data.

Ginkgo Biloba, Memory and General Cognitive Functions

Beyond its traditional use, Ginkgo biloba has been the subject of much research to assess its impact on cognitive performance in healthy individuals and those with mild age-related decline.

Proposed Mechanisms of Action on the Brain

Several mechanisms could explain how Ginkgo biloba influences cognitive functions:

• Improved Cerebral Circulation: By inhibiting PAF and potentially promoting vasodilation (relaxation of blood vessels), Ginkgo may increase blood flow to the brain. Improved oxygen and nutrient supply is essential for proper neuronal function.
• Antioxidant Effects: Flavonoids help protect brain cells against oxidative stress, a factor involved in brain aging and neurodegenerative diseases.
• Neurotransmitter Modulation: Some studies suggest that Ginkgo may influence the levels or activity of certain neurotransmitters (chemical messengers in the brain) important for memory and learning, such as acetylcholine, dopamine, and norepinephrine.
• Neuroprotection: Bilobalide and other components may protect neurons against various types of damage, including that caused by lack of oxygen (ischemia) or excess glutamate (excitotoxicity).
• Reduction of Blood Viscosity: In addition to improving flow, Ginkgo may make the blood slightly less "thick", facilitating its circulation in small cerebral vessels.

What does science say about healthy people?

The results of studies on the effects of Ginkgo biloba in healthy adults (young or middle-aged) are mixed and often contradictory . Some short-term studies have reported slight improvements in attention, information processing speed, or certain aspects of memory after taking Ginkgo. However, many other studies, including systematic reviews and meta-analyses (which combine the results of multiple studies), have found no convincing evidence of a significant benefit on memory or other cognitive functions in healthy individuals.

The observed effects, when they exist, are generally subtle, and their clinical relevance remains debated. There is no solid scientific consensus to recommend Ginkgo biloba as a cognitive "booster" for people without diagnosed cognitive impairment.

Considerations Regarding Dosage and Duration of Use

Most studies showing effects (even modest ones) used dosages of standardized EGb 761 extract ranging from 120 mg to 240 mg per day , often divided into two or three doses. The Ginkgo biloba DETOX box contains 120 mg capsules, which corresponds to the lower end of the dosage range studied. One capsule per day (120 mg) or two (240 mg) would therefore correspond to the dosage regimens commonly used in research.

It is also important to emphasize that the potential effects of Ginkgo are not immediate. Prolonged use over several weeks, or even several months , is generally considered necessary before any potential benefit can be assessed.

The Crucial Question: Ginkgo Biloba and Dementia

It is in the field of age-related cognitive decline and dementia that Ginkgo biloba has generated the most hope, but also the most scientific controversy.

What is Dementia?

Dementia is not a specific disease, but a general term describing a severe decline in mental abilities (memory, thinking, language, judgment) significant enough to interfere with daily life. Alzheimer's disease is the most common cause of dementia, characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. Vascular dementia , the second most common cause, results from brain damage caused by circulatory problems (stroke, microinfarction).

Initial Hopes and the Logic of Use

Interest in Ginkgo for treating dementia stemmed logically from its presumed mechanisms of action: improved cerebral circulation (relevant for vascular dementia), and antioxidant and neuroprotective effects (relevant for Alzheimer's and other forms of neurodegeneration). Early studies, often smaller in size or of lower methodological quality, had suggested potential benefits, fueling hopes for a natural solution.

The Results of Large Clinical Studies: A Cold Shower

Over the past two decades, several large, long-term, randomized, placebo-controlled clinical trials have been conducted to rigorously evaluate the efficacy of Ginkgo biloba in the prevention or treatment of dementia. The results of these high-quality studies have been largely disappointing:

• The GEM (Ginkgo Evaluation of Memory) study: Conducted in the United States on over 3,000 participants aged 75 and older, followed for an average of over 6 years. It concluded that Ginkgo biloba (at a dose of 120 mg twice daily) was not effective in reducing the overall incidence of dementia or Alzheimer's disease in older adults, regardless of whether they had normal cognitive function or mild cognitive impairment (MCI) at baseline.
• The GuidAge study: Conducted in France on over 2,800 participants aged 70 and older, followed for 5 years. It also aimed to evaluate the effectiveness of Ginkgo biloba (120 mg twice daily) in preventing Alzheimer's disease. Its results corroborated those of the GEM study, showing no significant preventive benefit of Ginkgo compared to placebo.
• Other studies and meta-analyses: Numerous systematic reviews and meta-analyses (including those from the Cochrane Collaboration) have examined all available evidence. Their general conclusion is that Ginkgo biloba does not demonstrate convincing effects in preventing cognitive decline or dementia, nor in significantly treating the cognitive symptoms of dementia once established.

Nuances: Modest Effects on Certain Symptoms?

Despite these largely negative results regarding prevention and overall treatment, some analyses suggest that Ginkgo biloba may have modest and limited effects on certain specific aspects in people already suffering from dementia (primarily Alzheimer's or mild to moderate vascular dementia). These potential effects would concern:

• A slight improvement in some cognitive symptoms (attention, processing speed).
• A possible improvement in certain behavioral and psychological symptoms of dementia (BPSD), such as apathy or anxiety.
• An improvement in the overall clinical impression reported by physicians or caregivers in some studies.

However, these potential benefits are considered small, inconsistent across studies, and their clinical relevance is often deemed limited. Furthermore, Ginkgo does not stop or slow the underlying progression of the disease.

Current Scientific Consensus and Recommendations

In light of current evidence (April 2025), the scientific consensus and recommendations of leading health organizations (such as the World Health Organization, national health authorities in Europe and North America) are clear:

Ginkgo biloba is NOT recommended as a first-line treatment or as a proven prevention strategy for dementia or Alzheimer's disease. Evidence of its effectiveness is considered insufficient or unconvincing, particularly in light of the results of large prevention studies.

Although it may offer very modest symptomatic relief to some already diagnosed patients, it should never replace validated medical and non-drug approaches for the management of dementia.

Use of "Ginkgo biloba DETOXIFICATION 120mg": Safety and Practical Considerations

Although evidence of effectiveness, particularly for dementia, is limited, it is crucial to be aware of the safety aspects if considering taking this supplement.

Dosage and Administration (120mg Capsules)

As mentioned, a dose of 120 mg (one capsule of the specified product) once or twice daily corresponds to the dosages used in many studies. It is generally advised to take the capsules with a glass of water, during meals, to potentially reduce gastrointestinal upset.

Possible Side Effects

Ginkgo biloba is generally considered well-tolerated when taken at the recommended doses. However, side effects may occur, although they are often mild and temporary:

• Gastrointestinal disorders: nausea, stomach ache, diarrhea.
• Headaches.
• Dizziness.
• Allergic skin reactions (rare).

Who Should Be Particularly Cautious or Avoid Ginkgo?

• People taking anticoagulant or antiplatelet medication (see above).
• People who are about to undergo surgery or dental work (it is recommended to stop taking Ginkgo at least 1 to 2 weeks before).
• People with clotting disorders (hemophilia...).
• Pregnant or breastfeeding women (lack of safety data).
• People with epilepsy (a few rare cases of seizures have been reported, although a direct causal link is uncertain).

Discover other products from the Herbal D-Tox collection

Conclusion: Ginkgo Biloba - Limited Potential, Caution Essential

Analysis of current scientific data (April 2025) concerning Ginkgo biloba , including 120mg capsules, leads to a nuanced but clear conclusion, especially regarding dementia:

• Prevention and Treatment of Dementia: Strong scientific evidence from large clinical studies indicates that Ginkgo biloba is not effective in preventing dementia (including Alzheimer's disease) in older adults. Its usefulness as a primary treatment for the cognitive symptoms of dementia is also considered limited and inconclusive by the majority of the scientific community.
• General Cognitive Functions: In healthy individuals, the effects of Ginkgo on memory and cognition are at best modest and inconsistent . It is not considered a reliable cognitive "booster".
• Safety and Interactions: Although generally well tolerated, Ginkgo presents a significant risk of drug interactions , particularly with anticoagulants and antiplatelet agents, increasing the risk of bleeding. This precaution is essential.

Consequently, while Ginkgo biloba may be perceived by some as a potential support for general well-being or circulation, it should never be considered an alternative to validated medical treatments , especially for a condition as serious as dementia. The hope it inspires should not obscure the lack of robust evidence of its effectiveness in this area.

Consulting a healthcare professional before use is absolutely essential to assess the real potential benefits versus risks, check interactions, and discuss evidence-based strategies for preventing and managing cognitive decline.